THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING CANCER
A compound of Formula II or a pharmaceutically acceptable salt thereof, wherein CyN is a cyclic amine group bound via a nitrogen atom; X is C or N; R1 and R2 are each independently a halogen, CN, CF3, CHF2, CH2F, a C1-C10alkyl group, a C1-C10alkoxy group, a di(C1-C5alkyl)amino; m and n are each inde...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A compound of Formula II or a pharmaceutically acceptable salt thereof, wherein CyN is a cyclic amine group bound via a nitrogen atom; X is C or N; R1 and R2 are each independently a halogen, CN, CF3, CHF2, CH2F, a C1-C10alkyl group, a C1-C10alkoxy group, a di(C1-C5alkyl)amino; m and n are each independently 1, 2, or 3, and represents either a single bond or a double bond, wherein the racemic mixture of 3-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2-ethyl-5-methoxyphenyl)-6-(2-methylprop-1-en-1-yl)-5-(piperazine-1-carbonyl)pyridin-2(1H)-one atropisomers is excluded.
Un composant de la formule II ou d'un sel pharmaceutiquement accepté de celui-ci, où CyN est un groupe d'amine cyclique lié par un atome d'hydrogène; X est C ou N; R1 et R2 sont chacun indépendant d'un halogène, CN, CF3, CHF2, CH2F, a C1-C10 groupe alkyle, a C1-C10 groupe alkoxy, a di(C1-C5alkyle)amino;m et n sont chacun indépendant de 3-(4-(4-chlorophényle)thiazole-2-yl)-1-(2-éthyle-5-méthoxyphenyle)-6-(2-méthylprop-1-en-1-yl)-5-(piperazine-1-carbonyl)pyridine-2(1H)-un atropisomère est exclu. |
---|